Clinical Trials Browser

Completed × Carcinoma, Hepatocellular × Antibodies × Clear all

NCT04618367 2024-03-06

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms